DOVONEX / potential risk to the fetus
United States · event evidence
potential risk to the fetus
Under review
Pregnancy; use during pregnancy is conditioned on the potential benefit justifying the potential fetal risk.
- Authority
- DailyMed, U.S. National Library of Medicine
- Document
- DOVONEX (CALCIPOTRIENE) CREAM [PHYSICIANS TOTAL CARE, INC.]
- Jurisdiction
- United States
- Version / revision
- 1
- Document date
- Not recorded
Source evidence
Therefore, Dovonex® Cream should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
- Section
- Not stated
- Context
- Pregnancy; use during pregnancy is conditioned on the potential benefit justifying the potential fetal risk.
- Frequency
- Not stated
- Population / denominator
- Not stated
Return to label evidence explorer